HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Positive Outcomes for iSTAR Medical’s MIGS MINIject

The final two-year data from the STAR-I trial and the six-month follow-up data from the STAR-II European trial, which are comprised in the pooled analysis, will both be presented at the upcoming European Society of Cataract and Refractive Surgery (ESCRS) meeting on October 2-4. The six-month primary endpoint results from the STAR-II trial of MINIject have recently been published in the peer-reviewed Journal of Glaucoma, the official publication of the World Glaucoma Association.

First-in-Human Implantation of Saturn Transcatheter Mitral Valve Reported Successful

The Trans-Apical TMVR procedure was performed as part of an on-going European clinical trial on August 19, 2020 at Santaros Klinikos University Hospital in Vilnius, Lithuania with the Heart Team of Kęstutis Ručinskas, MD, Audrius Aidietis MD, Vilius Janušauskas, MD, and Valdas Bilkis, MD supported by Paolo Denti, MD and Stefano Stella, MD.

Medtronic Reports the First Enrollments in the ALLEVIATE-HF Clinical Trial to Evaluate the Ability of Reveal LINQ Insertable Cardiac Monitor

The LINQ device will alert clinicians if a patient is at high risk for a heart failure event, allowing time for a physician to adjust medications to enhance patient health.

First Patient Enrollment in AAA-SHAPE Study – IMPEDE-FX Embolization Plug Devices Used for AAA Sac Filling During Elective EVAR Repair

The beginning of enrollment is a significant milestone for the Company as we continue to evaluate the potential of this novel application in aortic therapies.” The study will enroll up to 15 patients outside of the United States.

AVITA Therapeutics States 1st Patient Enrolled in Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo

AVITA Therapeutics Chief Executive Officer, “The initiation of the vitiligo clinical study is a milestone in advancing AVITA Therapeutic’s pipeline to leverage the utility and full potential of our innovative RECELL technology platform to address unmet medical needs in dermatological applications.

Concept Medical Reports Index Patient Enrollment in World’s 1st RCT with Sirolimus Coated Balloon

Concept Medical notes the index patient was successfully enrolled on 11th September in Singapore.

NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients

NaviFUS Corporation notes researchers at Linkou Chang Gung Memorial Hospital are investigating the use of Neuronavigation-guided FUS to repeatedly and temporarily open the blood-brain barrier and enhance bevacizumab's efficacy in patients with recurrent glioblastoma.

Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial

EXIT COVID-19 has initiated enrollment of 75 COVID-19 patients with moderate-to-severe ARDS at multiple research sites across the U.S. The primary efficacy endpoints will be all-cause mortality and median days to recovery.

NeuroSense Therapeutics Announces Encouraging Interim Results of Clinical Study in ALS

The study, containing 15 patients, is scheduled to continue for an additional 6 months.